Malignant Brain Neoplasm: Clinical Trials

7 trials for Malignant Brain Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 active not recruiting, 1 completed, 1 withdrawn. 7 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Recruiting 3, Active not recruiting 2, Completed 1, Withdrawn 1
Phase 21Recruiting 1

Follow Malignant Brain Neoplasm: new trials by email Literature Review of Malignant Brain Neoplasm trials Research Report on Malignant Brain Neoplasm

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma
Phase 1Active not recruitingJonsson Comprehensive Cancer Center302025-08-012026-10-20
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
Advanced Magnetic Resonance Imaging, Brain Surgery, Electronic Health Record Review - Glioma, Malignant Brain Neoplasm
Phase 1RecruitingJonsson Comprehensive Cancer Center202024-12-052026-02-05
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
Etoposide, Fludarabine Phosphate, Hematopoietic Cell Transplantation - Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor
Phase 1WithdrawnM.D. Anderson Cancer Center2021-01-142024-10-26
CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
Cyclophosphamide, Fludarabine, IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes - Malignant Brain Neoplasm, Recurrent Malignant Brain Neoplasm
Phase 1RecruitingCity of Hope Medical Center182020-12-112026-10-15
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
Computed Tomography, Gallium Ga 68 FAPi-46, Positron Emission Tomography - Bladder Carcinoma, Cervical Carcinoma
Phase 1Active not recruitingJonsson Comprehensive Cancer Center262020-08-272026-11-06
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Biospecimen Collection, Genetic Counseling, Genetic Testing - Breast Carcinoma, Digestive System Neoplasm
Phase 1CompletedMayo Clinic2302020-06-292023-07-24
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
Near-Infrared Fluorescence Imaging, Panitumumab, Panitumumab-IRDye800 - Malignant Brain Neoplasm, Malignant Glioma
Phase 1 / Phase 2RecruitingStanford University462018-05-162026-06-29

Narrower conditions

Brain Neoplasms (7)  ·  Glioma (3)  ·  Adrenal Gland Neoplasms (2)  ·  Breast Neoplasms (2)  ·  Carcinoma, Hepatocellular (2)  ·  Carcinoma, Transitional Cell (2)  ·  Cholangiocarcinoma (2)  ·  Neoplasms, Unknown Primary (2)  ·  Neuroendocrine Tumors (2)  ·  Testicular Neoplasms (2)  ·  Thyroid Neoplasms (2)  ·  Urinary Bladder Neoplasms (2)  ·  Uterine Cervical Neoplasms (2)  ·  Anus Neoplasms (1)  ·  Carcinoma, Medullary (1)

Broader conditions

Brain Diseases (7)  ·  Central Nervous System Diseases (7)  ·  Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Nervous System Diseases (7)  ·  Nervous System Neoplasms (7)  ·  Central Nervous System Neoplasms (6)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms, Germ Cell and Embryonal (5)  ·  Neoplasms, Glandular and Epithelial (5)  ·  Neoplasms, Nerve Tissue (5)  ·  Neuroectodermal Tumors (5)  ·  Digestive System Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)

Interventions

Magnetic Resonance Spectroscopy (3)  ·  FAPI-46 (2)  ·  Fluorodeoxyglucose F18 (2)  ·  Antilymphocyte Serum (1)  ·  Cyclophosphamide (1)  ·  Etoposide (1)  ·  Genetic Counseling (1)  ·  Genetic Testing (1)  ·  Hematopoietic Stem Cell Transplantation (1)  ·  Melphalan (1)  ·  Mycophenolic Acid (1)  ·  Panitumumab (1)  ·  Stem Cell Transplantation (1)  ·  Tacrolimus (1)  ·  Thiotepa (1)

Sponsors

Jonsson Comprehensive Cancer Center (3)  ·  City of Hope Medical Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  Stanford University (1)

Countries

United States (6)

Top investigators

Jeremie Calais (2)  ·  Kris M Mahadeo, MD (1)  ·  Leo D Wang (1)  ·  Lindsay Moore, MD (1)  ·  Niloy J Samadder (1)  ·  Robert M Prins (1)

NIH funding

P30CA016042 (1), P30CA033572 (1), P50CA211015 (1), R01CA190306 (1), R01CA267726 (1)